Network meta-analysis: a powerful tool for clinicians, decision-makers, and methodologists
Ivan D Florez1, Juan E De La Cruz-Mena2, Areti-Angeliki Veroniki3
1Department of Pediatrics, University of Antioquia, Medellin, Colombia; Pediatric Intensive Care Unit, Clínica Las Américas-AUNA, Medellin, Colombia; School of Rehabilitation Science, McMaster University, Hamilton, Canada.
Abstract:
Network Meta-analysis (NMA) is an advanced statistical method that combines direct evidence (ie, from head-to-head comparisons) and indirect evidence (ie, estimated from the direct available evidence) to obtain network estimates. NMAs are helpful to determine the comparative effectiveness of interventions that have not been directly compared and may provide more precise estimates for those comparisons that have been directly compared. NMA provides hierarchies which can be helpful for decision-making, much more in scenarios when multiple interventions exist for the same indication. In this article we provide a summary of the key concepts that users, namely, clinicians and methodologists need to consider when using an NMA to inform decision making.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Clinical Trials
There are four phases in a clinical trial. A phase one...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hazard Ratio
For example, in a clinical trial...


